Fortis Capital Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Fortis Capital Advisors, LLC holds 16 biotech & pharma companies tracked by BioSniper, totaling $15.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$15.0M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 15,862 | $3.4M |
| LLYELI LILLY & Co | 3,207 | $3.0M |
| MRNAModerna, Inc. | 34,042 | $1.7M |
| JNJJOHNSON & JOHNSON | 3,774 | $923K |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | 27,467 | $908K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,980 | $884K |
| ABTABBOTT LABORATORIES | 7,207 | $740K |
| BMYBRISTOL MYERS SQUIBB CO | 12,042 | $730K |
| PFEPFIZER INC | 22,180 | $623K |
| MRKMerck & Co., Inc. | 3,668 | $441K |
| GILDGILEAD SCIENCES, INC. | 3,049 | $425K |
| GALTGALECTIN THERAPEUTICS INC | 106,139 | $296K |
| AMGNAMGEN INC | 777 | $273K |
| PMPhilip Morris International Inc | 1,495 | $247K |
| KLRSKalaris Therapeutics, Inc. | 40,000 | $231K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 10,178 | $188K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.